Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ImPRESS: Losartan in brain tumors
NCT03951142Phase 2Unknown
- Start
- Oct 2019
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of losartan in glioblastoma (GBM) and brain metastases (3 arms). Primary endpoints: Relative cerebral blood flow by MRI at Day 270 and Relative solid stress by MRI at Day 270. Status: unknown.
02
Drugs
losartan
03
Conditions
glioblastoma (GBM)brain metastases
Beyond the preview
Go deeper on NCT03951142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03951142.